Literature DB >> 20042322

Osthol regulates hepatic PPAR alpha-mediated lipogenic gene expression in alcoholic fatty liver murine.

Fan Sun1, Mei-lin Xie, Jie Xue, Heng-bin Wang.   

Abstract

Our previous studies found that osthol, an active constituent isolated from Cnidium monnieri (L.) Cusson (Apiaceae), could ameliorate the accumulation of lipids and decrease the lipid levels in serum and hepatic tissue in alcohol-induced fatty liver mice and rats. The objective of this study was to investigate its possible mechanism of the lipid-lowering effect. A mouse model with alcoholic fatty liver was induced by orally feeding 52% erguotou wine by gavage when they were simultaneously treated with osthol 10, 20, 40 mg/kg for 4 weeks. The BRL cells (rat hepatocyte line) were cultured and treated with osthol at 25, 50, 100, 200 microg/ml for 24h. The mRNA expressions of peroxisome proliferator-activated receptor (PPAR) alpha, diacylglycerol acyltransferase (DGAT), 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase and cholesterol 7 alpha-hydroxylase (CYP7A) in mouse hepatic tissue or cultured hepatocytes were determined by reverse transcription polymerase chain reaction (RT-PCR). After treatment with osthol, the PPAR alpha mRNA expression in mouse liver and cultured hepatocytes was increased in dose dependent manner, while its related target genes for mRNA expression, e.g., DGAT and HMG-CoA reductase, were decreased, the CYP7A was inversely increased. And osthol-regulated mRNA expressions of DGAT, HMG-CoA reductase and CYP7A in the cultured hepatocytes were abrogated after pretreatment with specific inhibitor of PPAR alpha, MK886. It was concluded that osthol might regulate the gene expressions of DGAT, HMG-CoA reductase and CYP7A via increasing the PPAR alpha mRNA expression. (c) 2009 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042322     DOI: 10.1016/j.phymed.2009.10.021

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  14 in total

1.  Eicosapentaenoic Acid-Enriched Phosphatidylcholine Attenuated Hepatic Steatosis Through Regulation of Cholesterol Metabolism in Rats with Nonalcoholic Fatty Liver Disease.

Authors:  Yanjun Liu; Di Shi; Yingying Tian; Yuntao Liu; Qiping Zhan; Jie Xu; Jingfeng Wang; Changhu Xue
Journal:  Lipids       Date:  2016-12-24       Impact factor: 1.880

2.  PPARα/γ antagonists reverse the ameliorative effects of osthole on hepatic lipid metabolism and inflammatory response in steatohepatitic rats.

Authors:  Xi Zhao; Feng Wang; Ruijun Zhou; Zengyan Zhu; Meilin Xie
Journal:  Inflammopharmacology       Date:  2017-02-25       Impact factor: 4.473

3.  Metabolic map of osthole and its effect on lipids.

Authors:  Qi Zhao; Xin-Mei Li; Hong-Ning Liu; Frank J Gonzalez; Fei Li
Journal:  Xenobiotica       Date:  2017-04-03       Impact factor: 1.908

4.  Osthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistance.

Authors:  Ho Hyun Nam; Dae Won Jun; Hye Joon Jeon; Jai Sun Lee; Waqar Khalid Saeed; Eun Kyung Kim
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

5.  Clostridium butyricum MIYAIRI 588 improves high-fat diet-induced non-alcoholic fatty liver disease in rats.

Authors:  Makoto Seo; Ikuo Inoue; Mamoru Tanaka; Noriko Matsuda; Takanari Nakano; Takuya Awata; Shigehiro Katayama; David H Alpers; Tsugikazu Komoda
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

6.  The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides.

Authors:  Foteini Malliou; Ioanna Andreadou; Frank J Gonzalez; Antigone Lazou; Eva Xepapadaki; Ioanna Vallianou; George Lambrinidis; Emmanuel Mikros; Marios Marselos; Alexios-Leandros Skaltsounis; Maria Konstandi
Journal:  J Nutr Biochem       Date:  2018-06-05       Impact factor: 6.048

7.  Selected Extracts of Chinese Herbal Medicines: Their Effect on NF-κB, PPARα and PPARγ and the Respective Bioactive Compounds.

Authors:  E Rozema; A G Atanasov; N Fakhrudin; J Singhuber; U Namduang; E H Heiss; G Reznicek; C W Huck; G K Bonn; V M Dirsch; B Kopp
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-23       Impact factor: 2.629

8.  Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.

Authors:  Songtao Li; Xilu Liao; Fanyu Meng; Yemei Wang; Zongxiang Sun; Fuchuan Guo; Xiaoxia Li; Man Meng; Ying Li; Changhao Sun
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 9.  Osthole: A Review on Its Bioactivities, Pharmacological Properties, and Potential as Alternative Medicine.

Authors:  Zhong-Rong Zhang; Wing Nang Leung; Ho Yee Cheung; Chun Wai Chan
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

10.  Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation.

Authors:  Ya-Wei Liu; Yung-Tsung Chiu; Shu-Ling Fu; Yi-Tsau Huang
Journal:  J Biomed Sci       Date:  2015-08-01       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.